|
|
Angela GillespieAngela Gillespie, who returned to W2O two years ago as healthcare practice leader & chief strategy officer, has been named president of its W2O wcg unit. She reports to Jennifer Gottlieb, W2O president.
Gillespie has more than 20 years of healthcare marketing experience, supporting the initiatives of pharmaceutical, consumer health, device/diagnostic and payer/provider networks.
She exited WCG in 2010 for a series of key posts at Boston Scientific (clinical strategist/educator), Covidien (venous vascular therapies unit market development leader) and NeuWave Medical (VP-marketing).
"Angela took a leap mid-way through her career, evolving her skill set to become today's necessary hybrid marketing and communications professional," said Gottlieb in a statement.
She considers Gillespie "a formidable and well-regarded force in healthcare."
Gillespie owns Gillespie Family Wines in Argentina.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
